The application of fecal microbiota transplantation in Parkinson’s disease
FMT has demonstrated efficacy in ameliorating PD symptoms via the MGBA. However, further preclinical and clinical studies are needed to fully elucidate its mechanisms and optimize therapeutic protocols. Targeting the gut microbiota may offer novel biomarkers and intervention strategies for PD.
Authors
- Tianfei Luo
- Na Li (ORCID: https://orcid.org/0000-0002-4112-0944)
- Boyan Wang (ORCID: https://orcid.org/0000-0002-3856-7032)
- Di Ma (ORCID: https://orcid.org/0000-0002-3555-1481)
Institutions
- Jilin University (CN)
- First Hospital of Jilin University (CN)
Publication Details
- Journal
- Frontiers in Aging Neuroscience
- Published
- 2025-12-17
- DOI
- https://doi.org/10.3389/fnagi.2025.1713899
- Primary Topic
- Gut microbiota and health
- Type
- article
- Field-Weighted Citation Impact
- 0.00